Bruker (NASDAQ: BRKR) reported Q1 EPS of $0.14, $0.09 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $424 million versus the consensus estimate of $444.4 million.

Fiscal Year 2020 (FY 2020) Guidance Remains Suspended

On March 27, 2020, Bruker suspended its FY 2020 financial guidance due to the uncertain business conditions created by COVID-19. Bruker anticipates that the pandemic will have a more significant negative impact on the Company’s second quarter 2020 financial results.

For earnings history and earnings-related data on Bruker (BRKR) click here.